Cargando…
Modified mRNA as a Treatment for Myocardial Infarction
Myocardial infarction (MI) is a severe disease with high mortality worldwide. However, regenerative approaches remain limited and with poor efficacy. The major difficulty during MI is the substantial loss of cardiomyocytes (CMs) with limited capacity to regenerate. As a result, for decades, research...
Autores principales: | Wang, Yu, Wu, Meiping, Guo, Haidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003380/ https://www.ncbi.nlm.nih.gov/pubmed/36902165 http://dx.doi.org/10.3390/ijms24054737 |
Ejemplares similares
-
mRNA therapy for myocardial infarction: A review of targets and delivery vehicles
por: Wang, Xinming, et al.
Publicado: (2022) -
Identification of ceRNA (lncRNA-miRNA-mRNA) Regulatory Network in Myocardial Fibrosis After Acute Myocardial Infarction
por: Wang, Shuo, et al.
Publicado: (2021) -
Modified mRNA Therapeutics for Heart Diseases
por: Magadum, Ajit
Publicado: (2022) -
The Effect of Wenxin Keli on the mRNA Expression Profile of Rabbits with Myocardial Infarction
por: Zheng, Min, et al.
Publicado: (2016) -
Construction and Bioinformatics Analysis of circRNA-miRNA-mRNA Network in Acute Myocardial Infarction
por: Zhou, Jin, et al.
Publicado: (2022)